The Preventive Effect of Ulinastatin on Blood–Brain Barrier Dysfunction in Rats with Postoperative Cognitive Dysfunction After General Anaesthesia with Isoflurane
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312505 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Eun-Hwa Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection and Immunology, Konkuk University School of Medicine, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Isoflurane, Anesthesia, General, Postoperative Cognitive Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hanlim Pharm., Korea.
Abstract (Originalsprache)
This study evaluated the effect of ulinastatin on blood–brain barrier (BBB) dysfunction in rats with postoperative cognitive dysfunction (POCD) following general anaesthesia with isoflurane. Specifically, we examined BBB permeability and the expression of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Rats in the ulinastatin group received the drug intraperitoneally (50,000 U/mL), while controls received normal saline (1 mL) administered before general anaesthesia. Isoflurane (1.5% volume) anaesthesia was induced for 2 h. Cognitive function was assessed using the Y-maze test. Two days after anaesthesia, BBB permeability was measured using Evans blue, and TIMP-1 expression was evaluated. Both groups experienced cognitive decline following anaesthesia. However, the ulinastatin group showed a more limited decrease (control group, 64.2 ± 19.3 → 30.2 ± 16.2, p = 0.008; ulinastatin group, 70.0 ± 15.7 → 66.5 ± 12.0, p = 0.67). The ulinastatin group showed a significantly lower permeability of the BBB (0.034 ± 0.003 µg/g in control group vs. 0.005 ± 0.002 µg/g in ulinastatin group, p = 0.0001), and also showed a significantly higher value of TIMP-1 expression (5.81 ± 1.94% in control group vs. 13.97 ± 2.59% in ulinastatin group, p = 0.0001). Administration of ulinastatin before general anaesthesia mitigated cognitive decline in rats with POCD, likely through the prevention of BBB dysfunction, as evidenced by the lower BBB permeability and increased TIMP-1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection and Immunology, Konkuk University School of Medicine, Seoul 05029, Republic of Korea.
- BK21 Plus, Department of Cellular and Molecular Medicine, Konkuk University School of Medicine, Seoul 05029, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea.
- Department of Medicine, Institute of Biomedical Science and Technology, Konkuk University School of Medicine, Seoul 05029, Republic of Korea.
- Department of Medical Education, Konkuk University School of Medicine, Seoul 05030, Republic of Korea.
ORCID-Profile: Eun-Hye Seo, Seung-Wan Hong, Seong-Hyop Kim
Förderung
- Hanlim Pharm., Korea
Zitieren
APA
Cho, E. H., Seo, E. H., Hong, S. W., & Kim, S. H. (2024). The Preventive Effect of Ulinastatin on Blood–Brain Barrier Dysfunction in Rats with Postoperative Cognitive Dysfunction After General Anaesthesia with Isoflurane. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312505
Vancouver
Cho EH, Seo EH, Hong SW, Kim SH. The Preventive Effect of Ulinastatin on Blood–Brain Barrier Dysfunction in Rats with Postoperative Cognitive Dysfunction After General Anaesthesia with Isoflurane. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312505
BibTeX
@article{Cho2024,
author = {Cho, Eun-Hwa and Seo, Eun-Hye and Hong, Seung-Wan and Kim, Seong-Hyop},
title = {The Preventive Effect of Ulinastatin on Blood–Brain Barrier Dysfunction in Rats with Postoperative Cognitive Dysfunction After General Anaesthesia with Isoflurane},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312505}
}
EUVIMED